John G. Clarkson

John G. Clarkson discloses dealings in Noven Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 23 May 2006 to 27 August 2009, the count stands at 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 27 August 2009 came the latest disclosure, a transaction for €105k in Noven Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.